Tiziana Bummer

Establishment of screening plattforms and assays for identification of new targets for various cardiovascular diseases and other therapeutical areas. Modification of primary cells and cell lines using different genetic engineering methods to study disease relevant pathways.

Self-organized planning and establishment of in vitro assays to study various immunological pathways involved in cancer development and other immune diseases. Responsible for performance of multicolor flow cytometry analysis as well as training of students and new employees.

Analysis of the role of regulatory T-cells in priming of anti-tumor immune responses. Performance of various co-culture assays and multicolor FACS experiments, as well as isolation and culture of primary human immune cells.

Troubleshooting in a lyophilisate drug product development project, including optimization of the lyophilisation process and the formulation of sucrose based formulations.

Analysis of patient samples from vaccination trials via multicolor flow cytometry.

Identification and selection of nanobodies via phage display technologies.

Analysis of glioblastoma stem-cells with flow cytometry and molecular biological methods.